Suchergebnisse - "Itolizumab"

PubPharm (26)

1

Comparative evaluation of tocilizumab and itolizumab for treatment of severe COVID-19 in India : a retrospective cohort study

enthalten in: Acute and critical care | 2024

von Kumar, A. | Kumar, N. | Pattanayak, A. | +4

2

REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19 : a multicenter, single-arm, Phase IV itolizumab Trial: RESURRECT

enthalten in: Expert opinion on biological therapy | 2023

von Kr, R. | Rathod, C. | Darnule, R. | +8

3

Role of Itolizumab in the Treatment of COVID-19 Patients, Admitted to ICU at a Tertiary Care Hospital

enthalten in: The Journal of the Association of Physicians of India | 2022

von Kurri, N. | Tyagi, B. | Kaushik, A. | +3

4

Adverse drug reactions of itolizumab in COVID-19 patient : A case report

enthalten in: Indian journal of pharmacology | 2022

von Mohammed, Z. | Suryachandra, K. | Dandekar, M.

5

Pharmacological treatment of COVID-19 : an opinion paper

enthalten in: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia | 2022

von García-Lledó, A. | Gómez-Pavón, J. | González Del Castillo, J. | +12

6

Pulmonary Thrombosis in COVID-19 Treated by Thrombolysis : A Small Case Series Using Streptokinase

enthalten in: Seminars in thrombosis and hemostasis | 2021

von Caballero López, A. | Herrera Cartaya, C. | Chávez González, E. | +8

7

Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19

enthalten in: Indian journal of pharmacology | 2021

von Vityala, Y. | Tagaev, T. | Mamatov, S. | +2

8

A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19

enthalten in: Expert opinion on biological therapy | 2021

von Kumar, S. | De Souza, R. | Nadkar, M. | +7

9

Off-label Use of Itolizumab in Patients with COVID-19 ARDS : Our Clinical Experience in a Dedicated COVID Center

enthalten in: Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine | 2021

von Kumari, P. | Kumar, A. | Sinha, C. | +3

10

Monoclonal Antibodies vs COVID-19 : Eduardo Ojito-Magaz MS General Director, Molecular Immunology Center

enthalten in: MEDICC review | 2021

von Aguilar, T. | Gorry, C.